“Impact of Infections in Patients With Acute Myeloid Leukemia Receiving Cytarabine+ Daunorubicin (7+3) Versus Azacitidine and Venetoclax During Induction Chemotherapy”. Indus Journal of Bioscience Research, vol. 3, no. 1, Jan. 2025, pp. 190-6, https://doi.org/10.70749/ijbr.v3i1.469.